BioNTech SE (BNTX) Assets Average (2019 - 2025)

BioNTech SE (BNTX) has 7 years of Assets Average data on file, last reported at $25.3 billion in Q4 2025.

• For the quarter ending Q4 2025, Assets Average rose 3.84% year-over-year to $25.3 billion; the trailing twelve-month figure through Dec 2025 stood at $25.3 billion (up 3.84% YoY), and the FY2025 full-year result was $24.5 billion, changed 0.18% from the prior year.
• Assets Average rose to $25.3 billion in Q4 2025, from $24.7 billion in the prior quarter.
• In the past five years, Assets Average ranged from a high of $25.3 billion in Q4 2025 to a low of $3.9 billion in Q1 2021.
• A 5-year average of $21.1 billion and a median of $23.6 billion in 2023 frame the typical range for Assets Average.
• Across the five-year window, Assets Average soared 905.48% in 2021 and declined 5.26% in 2025, its largest moves.
• Tracing BNTX's Assets Average over 5 years: stood at $17.4 billion in 2021, then soared by 33.54% to $23.3 billion in 2022, then rose by 5.0% to $24.5 billion in 2023, then slipped by 0.51% to $24.3 billion in 2024, then rose by 3.84% to $25.3 billion in 2025.
• Business Quant data shows BNTX's Assets Average at $25.3 billion in Q4 2025, $24.7 billion in Q3 2025, and $23.4 billion in Q2 2025.